| Decision | Consent granted Section 13(1)(a) Overseas Investment Act 2005 |
|---|---|
| Decision Maker | Overseas Investment Office |
| Decision Date | 17 June 2021 |
| Pathway(s) | Significant business assets only National Interest assessment |
| Investment | Acquisition of securities and certain assets owned directly or indirectly by the Vendor. |
| Consideration | $147 million |
| Applicant | Herens HoldCo AG United States of America (31%) Canada (9.70%) Netherlands (7.50%) Various (7.15%) Cayman Islands (5.90%) Various (45.9%) |
| Vendor | Lonza Group AG Switzerland (100%) |
| Background | The Applicant is acquiring the ‘Lonza Specialty Ingredients’ business unit (LSI Business) of Lonza Group AG which is a Swiss multinational chemical and biotechnology company headquartered in Basel, Switzerland. The LSI Business specialises in microbial control for personal care, workplaces and the environment. The Applicant considers acquisition of the LSI Business aligns with its investment strategy. The LSI Business includes more than 70 companies including Lonza NZ Limited and Arch Wood Protection (NZ) Limited and Taranaki Nuchem Limited (wholly owned by Arch Wood Protection (NZ) Limited). The Applicant has satisfied the investor test criterion. The Minister of Finance has determined that the Investment is not contrary to New Zealand’s national interest. |
| More information | Glenn Shewan Bell Gully PO Box 4199 Auckland 1140 |